Chicken oocyte growth: receptor-mediated yolk deposition.
During the rapid final stage of growth, chicken oocytes take up massive amounts of plasma components and convert them to yolk. The oocyte expresses a receptor that binds both major yolk lipoprotein precursors, vitellogenin (VTG) and very low density lipoprotein (VLDL). In the present study, in vivo transport tracing methodology, isolation of coated vesicles, ligand- and immuno-blotting, and ultrastructural immunocytochemistry were used for the analysis of receptor-mediated yolk formation. The VTG/VLDL receptor was identified in coated profiles in the oocyte periphery, in isolated coated vesicles, and within vesicular compartments both outside and inside membrane-bounded yolk storage organelles (yolk spheres). VLDL particles colocalized with the receptor, as demonstrated by ultrastructural visualization of VLDL-gold following intravenous administration, as well as by immunocytochemical analysis with antibodies to VLDL. Lipoprotein particles were shown to reach the oocyte surface by passage across the basement membrane, which possibly plays an active and selective role in yolk precursor accessibility to the oocyte surface, and through gaps between the follicular granulosa cells. Following delivery of ligands from the plasma membrane into yolk spheres, proteolytic processing of VTG and VLDL by cathepsin D appears to correlate with segregation of receptors and ligands which enter disparate sub-compartments within the yolk spheres. In small, quiescent oocytes, the VTG/VLDL receptor was localized to the central portion of the cell. At onset of the rapid growth phase, it appears that this pre-existing pool of receptors redistributes to the peripheral region, thereby initiating yolk formation. Such a redistribution mechanism would obliterate the need for de novo synthesis of receptors when the oocyte's energy expenditure is to be utilized for plasma membrane synthesis, establishment and maintenance of intracellular topography and yolk formation, and preparation for ovulation.
Shen
X
X
Department of Medicine, University of Manitoba, Winnipeg, Canada.
Steyrer
E
E
Retzek
H
H
Sanders
E J
EJ
Schneider
W J
WJ
D000818:Animals; D002402:Cathepsin D / Q000494:pharmacology; D002645:Chickens / Q000502:physiology*; D004527:Egg Proteins / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D004705:Endocytosis / Q000502:physiology; D005260:Female; D015151:Immunoblotting; D007150:Immunohistochemistry; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008854:Microscopy, Electron; D009865:Oocytes / Q000254:growth & development* / Q000502:physiology / Q000648:ultrastructure; D009866:Oogenesis / Q000502:physiology*; D011498:Protein Precursors / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000032:analysis / Q000378:metabolism / Q000502:physiology*; D018110:Receptors, Lipoprotein; D014819:Vitellogenins / Q000378:metabolism
D004527:Egg Proteins; D008079:Lipoproteins, VLDL; D011498:Protein Precursors; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; D014819:Vitellogenins; C030474:vitellogenin receptor; D002402:Cathepsin D